1. Abstract There are two clinical features of autoimmune disease in the large intestine that we often find in our clinical practice, including ulcerative colitis and Crohn’s Disease. The clinical picture that we need to understand is the change in bowel patterns over the past few weeks. Clinical symptoms that appear need to be diagnosed …
Large Bowel Auto-Immune Diseases: Current Recommendation for Surgery Read More »
1. Clinical Image We present a 22-month-old girl affected by surgical palliative corrected Tetralogy of Fallot and peculiar facial features characterized by prominent forehead, deep-set eyes, pointed chin and bulbous tip of nose (Figure 1) typical of Alagille Syndrome (AS). Hypoplasia of the distal phalanges of both feet and two butterfly vertebrae at D10-D11 on …
Alagille Syndrome: Not Always Hepatic Involvement Read More »
1. Clinical Presentation A middle-age gentleman, residing in Singapore, presented with altered bowel habits for 2-week duration, associated with left iliac fossa pain, hematochezia and significant weight loss of 10kg. There was no significant travel history or sick contact preceding the symptoms. Physical examination was unremarkable, except for digital rectal examination which revealed in duration …
More Than Meets the Eyes – An Unusual Aetiology for Pan-Proctocolitis Read More »
1. Abstract Despite being a young domain with a one-generation history or so, evidence-based medicine has benefitted from thousands of contributions, as reflected in numerous book titles and subjects, and original articles. EBM-related philosophical insights are increasing as are endeavours in reasoning, modern argumentation, considerations of causality, and grading of evidence. DOI: http://dx.doi.org/10.47829/JJGH.2020.5302
1. AbstractThe domain of ‘Evidence-based medicine’ (also known as ‘EBM’) is increasingly ubiquitous across the medical literature and experience. It is just about one generation old and worthy of further refinements.Five related insights are outlined here:Among others, clinical epidemiology, fundamental and field epidemiology and biostatistics have led to EBM. DOI: http://dx.doi.org/10.47829/JJGH.2020.5303
1. Abstract In the past two or three decades, we have witnessed and built remarkable methodologies not only specific to the growing spectrum of clinical case reporting, but also diversified based on what we are doing, presenting, and evaluating as pertains to our daily experience with clinical cases. Yes, such endeavours are also research. This …
Clinical Case Reports, Case Series, Clinical Vignettes: Where Are We Today? Read More »
1. Abstract Evidence-Based Medicine is here to stay, and it is expanding, with evolving modifications, new topics, new research and teaching groups, and new recipients of information. Acronyms, as brief and condensed ways to present and understand ideas related to the above-mentioned phenomena, are also increasing in number and some, serious or funny, are worthy …
Acronymization of Evidence-Based and Other Medicines Anything Goes, or Should It? Read More »
1. Abstract 1.1. Introduction: Poorly Differentiated Adenocarcinomas (PDAC) and Signet ring adenocarcinomas (SRAC) are aggressive histologic subtypes of rectal cancer with high incidence of imaging occult peritoneal metastasis. 1.2. Methods: Retrospective review of aggressive histology, rectal cancer patients who underwent pre-treatment surgical staging as part of ovarian transposition or ostomy creation for diversion at a …
1. AbstarctTo mistrust science and deny the validity of the scientific method is to resign your job as a human. You’d better go look for work as a plant or wild animal. P.J. ORourke 1947- Parliament of Whores (1991).Just as Peter asked Jesus in the New Testament about two thousand years ago, Domine, quo vadis? …
1. Abstract Vonoprazan (VPZ) is more useful than proton pump inhibitor (PPI)-based regimen as H. pylori eradication therapy. It is controversial whether pretreatment with H2 receptor antagonist (H2RA) or PPI before H. pylori eradication treatment increases or decreases the eradication rate. In this retrospective study, 802 patients with H. pylori infection were treated. DOI:http://dx.doi.org/10.47829/JJGH.2020.5201
The Japanese Journal of Gastroenterology and Hepatology accepts all kinds of manuscripts, such as research, studies, reviews, clinical images, editorials, commentaries, etc.
For Detailed quotations reach out submission@jajogh.jp
It depends on the length of the manuscript and the reviews and edits needed.
We will help you with as many reviews and edits as are required to make your manuscript perfect for publication.
A good impact factor for JJGH is 2.0 as per Journal Citations Reports of 2021.
Niigata, 7F Stork Building Kagamibashi, 1230-7, 7-bancho, Kamiookawamaedori, Chuo-ku, Niigata, 951-8068, Japan.
*2021 Journal unofficial Impact Factor was established by dividing the number of articles published in 2020 with the number of times they are cited in 2021 based on Google Scholar Citation Index database. If ‘X’ is the total number of articles published in 2020 and ‘Y’ is the number of times these articles were cited in indexed journals during 2021 then, journal impact factor = Y/X.
Copyright 2018-2024 All Rights Reserved.